ISL1 and neuroblastoma: A set of six markers (CCND1, DDC, GABRB3, ISL1, KIF1A, PHOX2B) was identified by genome-wide gene expression microarray analyses of 48 neuroblastoma tumors and nine remission BM samples followed by selecting genes with higher tumor-to-BM expression ratios (110).